Refractory insulin allergy: pancreas transplantation or immunosuppressive therapy alone?
Jacqueline
J
Léonet
Jacques
J
Malaise
Jean-Paul
JP
Squifflet
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000191:economics / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D004342:Drug Hypersensitivity / Q000191:economics / Q000628:therapy*; D006801:Humans; D007165:Immunosuppression Therapy / Q000191:economics; D007328:Insulin / Q000009:adverse effects* / Q000276:immunology*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000191:economics / Q000627:therapeutic use; D000069444:Omalizumab; D016035:Pancreas Transplantation / Q000191:economics
D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007328:Insulin; D000069444:Omalizumab; D009173:Mycophenolic Acid